Jacksonville, FLORIDA2 Active Studies

Diabetic Retinopathy Clinical Trials in Jacksonville, FLORIDA

Find 2 actively recruiting diabetic retinopathy clinical trials in Jacksonville, FLORIDA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
660
Enrolling

Recruiting Diabetic Retinopathy Studies in Jacksonville

About Diabetic Retinopathy Clinical Trials in Jacksonville

Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.

There are currently 2 diabetic retinopathy clinical trials recruiting participants in Jacksonville, FLORIDA. These studies are seeking a combined 660 participants. Research is being sponsored by Jaeb Center for Health Research, Vantage Biosciences Ltd. Clinical trial participation is free and participants receive study-related medical care at no cost.

Diabetic Retinopathy Clinical Trials in Jacksonville — FAQ

Are there diabetic retinopathy clinical trials in Jacksonville?

Yes, there are 2 diabetic retinopathy clinical trials currently recruiting in Jacksonville, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Jacksonville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Jacksonville research site will contact you about next steps.

Are clinical trials in Jacksonville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Jacksonville studies also compensate for your time and travel.

What diabetic retinopathy treatments are being tested?

The 2 active trials in Jacksonville are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.

Data updated March 2, 2026 from ClinicalTrials.gov